UNSPSC 41181563: Thyroid autoantibody immunological test system

In this classification, a Thyroid autoantibody immunological test system is a device that consists of the reagents used to identify by immunochemical techniques Thyroid autoantibody. US FDA regulates Thyroid autoantibody immunological test system under 21 CFR 866.5870 and under FDA product code JZO.

UNSPSC 41181563 Thyroid autoantibody immunological test system is a Commodity code, but state and local procurement activity under this code shows little alignment with the nominal scope. Recent solicitations tagged with this code span laboratory testing services, equipment repair and maintenance, spectrophotometer procurement, oil analysis services, landscape engineering, system technical support, EV charger repair, construction materials testing, lab information management systems, electric utility meter test boards, water well construction, servo-hydraulic testing equipment, and lock-in amplifiers. None of these procurements involve thyroid autoantibody testing or immunological assays. The code appears to have been misapplied across a diverse set of laboratory and testing infrastructure acquisitions that fall outside its intended commodity scope.

The issuing bodies include county health departments and transit authorities (Marion County Oregon, Texas Department of State Health Services, Broward County Transportation), city utilities and departments (Tampa, Ocala, Palm Bay), university systems (Texas A&M, Lamar), and special-purpose districts (Lubbock Power & Light). Geographic activity spans Florida, Oregon, Texas, Connecticut, and other states. Representative recent opportunities include Marion County, Oregon's ITB for laboratory testing services and phlebotomy due July 24, 2026; Texas DSHS's IFB for laboratory equipment repair and maintenance due July 6, 2026 with historical annual value of $25,050 to $40,000; the City of Tampa's RFQ for a Heck DR4900 Spectrophotometer due June 12, 2026; and Lubbock Power & Light's RFP for oil testing laboratory services due July 22, 2026. Given the systematic mismatch between the code's stated product (thyroid autoantibody immunological test system) and the actual work being procured, pursuit under this code should be evaluated with caution — vendors should verify the intended commodity classification before bid preparation or qualification submissions.